10 /100
LOW RISK
Score updated Jul 14, 2026

NYT — The New York Times Company Dilution Risk Tracker

Track NYT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NYT — Get alerts when the score changes →

As of July 14, 2026, The New York Times Company (NYT) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. The New York Times Company has a market capitalization of $12.17B, 163.70M shares outstanding, 633 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NYT.
🔔 Track NYT — Get forecast alerts →

💹 Market Data

Market Cap$12.17B
Shares Outstanding163.70M
Float134.71M
Cash$594.52M
Debt$246.16M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 7.6% shares (2026Q1 vs prior)
633 institutional holders · 183.20M shares
#1 Berkshire Hathaway Inc 15.15M shares
#2 BlackRock, Inc. 15.13M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 13.96M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest14.07M
Days to Cover6.5
% of Float10.4%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
4 INSIDER TRANSACTION Apr 20, 2026
4 INSIDER TRANSACTION Apr 20, 2026
4 INSIDER TRANSACTION Apr 20, 2026
4 INSIDER TRANSACTION Apr 20, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NYT Shareholders

The New York Times Company (NYT) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for NYT shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for NYT in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NYT alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track NYT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NYT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NYT
📊 NYT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NYT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.